Prevalence, diagnosis, and treatment of hepatitis C in Mainland China
Author:
Affiliation:
1. Department of Severe Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
2. Department of Infections Disease, Shenzhen Third People’s Hospital, Shenzhen, China.
Publisher
National Center for Global Health and Medicine (JST)
Link
https://www.jstage.jst.go.jp/article/ghm/3/5/3_2021.01080/_pdf
Reference45 articles.
1. 1. World Health Organization. Global Hepatitis Report, 2017-New hepatitis data highlight need for urgent global response. 2017. https://www.who.int/news/item/21-04-2017-new-hepatitis-data-highlight-need-for-urgent-global-response (accessed September 12, 2021).
2. 2. Revill PA, Chisari FV, Block JM, et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019; 4:545-558.
3. 3. Chinese Center for Disease Control and Prevention. The status of notifiable infectious diseases in China in 2020. http://www.nhc.gov.cn/jkj/s3578/202103/f1a448b7df7d4760976fea6d55834966.shtml (accessed September 12, 2021). (in Chinese)
4. 4. World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. https://www.who.int/publications/i/item/9789241550345 (accessed September 12, 2021).
5. 5. Irshad M, Mankotia DS, Irshad K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol. 2013; 19:7896-7909.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study;PharmacoEconomics;2024-09-02
2. HCV RNA Positivity among Hepatitis C Patients in Chongqing, China from 2004 to 2021: A Cross-Sectional Study;2024-06-06
3. Epidemiological Features of Hepatitis C in China From 2015 to 2021: Insights From National Surveillance Data;Asia Pacific Journal of Public Health;2024-05-17
4. Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China;BMC Infectious Diseases;2024-04-29
5. Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis;JHEP Reports;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3